DNA staircase leading to a glowing brain.

Unlocking Alzheimer's: New Insights into LRP1 Gene and Risk Factors

Author's portrait.
Avery Sinclair in Health & Wellness August 2025 • 5 min read.

"A meta-analysis reveals the LRP1 C766T polymorphism's role in Alzheimer's susceptibility, especially among Asian populations and those with late-onset AD."


Alzheimer's disease (AD) poses a significant global health challenge, characterized by the accumulation of amyloid-beta plaques and neurofibrillary tangles in the brain. While the exact causes of AD remain complex, genetic factors, lifestyle, and environmental influences are all understood to play a role. Identifying specific genetic markers associated with AD risk is critical for early detection and the development of targeted prevention strategies.

One gene of interest in AD research is the low-density lipoprotein receptor-related protein 1 (LRP1). LRP1 is involved in clearing amyloid-beta from the brain and maintaining overall brain health. A specific variation (polymorphism) in the LRP1 gene, known as C766T, has been investigated for its potential link to AD susceptibility. However, the results of individual studies have often been conflicting.

To clarify the role of the LRP1 C766T polymorphism, a comprehensive meta-analysis was conducted. This type of study combines data from multiple individual studies to increase statistical power and provide a more reliable estimate of the true association. The meta-analysis included 26 independent case-control studies with a total of 6455 AD cases and 6304 controls, focusing on determining if there was a link between the LRP1 C766T polymorphism and the risk of developing Alzheimer's disease.

Decoding the LRP1 C766T Connection: What the Meta-Analysis Reveals

DNA staircase leading to a glowing brain.

The initial combined analysis showed no significant overall association between the LRP1 C766T polymorphism and AD susceptibility. However, when the researchers delved deeper and performed subgroup analyses based on ethnicity, striking differences emerged. It was found that among Asian populations, the T allele of the LRP1 C766T polymorphism was associated with a significantly decreased risk of AD, indicating a protective effect. Similarly, the T allele was also linked to a reduced risk of late-onset AD (LOAD).

Here's a breakdown of the key findings:

  • Overall Association: No significant association between LRP1 C766T polymorphism and AD susceptibility in the combined analysis of all populations.
  • Asian Subgroup: The T allele of LRP1 C766T was associated with decreased AD susceptibility in Asian populations (T versus C: OR = 0.786, 95% CI = 0.635-0.974, P = 0.028; TT + CT versus CC: OR = 0.800, 95% CI = 0.647-0.990, P = 0.040).
  • Late-Onset AD (LOAD): The T allele of LRP1 C766T was statistically associated with a reduced risk of LOAD (T versus C: OR = 0.858, 95% CI = 0.748-0.985, P = 0.029; TT + CT versus CC: OR = 0.871, 95% CI = 0.763-0.994, P = 0.040).
  • APOE ε4 Status: No significant interaction was observed for APOE ε4 status (P > 0.05).
These findings suggest that the LRP1 C766T polymorphism may have different effects on AD risk depending on an individual's genetic background and the specific type of AD. The protective effect observed in Asian populations and those with late-onset AD highlights the complexity of genetic influences on this disease.

Looking Ahead: Implications and Future Research

This meta-analysis provides valuable insights into the complex relationship between the LRP1 C766T polymorphism and Alzheimer's disease. The findings suggest that this genetic variation may contribute to a reduced risk of AD in certain populations, particularly those of Asian descent and those with late-onset AD. However, it is essential to acknowledge the limitations of this study, including potential variations in study design and population characteristics across the included studies. Further large-scale research is needed to confirm these findings and to fully understand the mechanisms by which the LRP1 C766T polymorphism influences AD risk. Future studies should also explore potential interactions between this genetic variation and other risk factors for Alzheimer's disease, such as lifestyle, environmental exposures, and other genetic markers.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1038/s41598-017-08335-w, Alternate LINK

Title: Association Between Lrp1 C766T Polymorphism And Alzheimer’S Disease Susceptibility: A Meta-Analysis

Subject: Multidisciplinary

Journal: Scientific Reports

Publisher: Springer Science and Business Media LLC

Authors: Yun Wang, Shengyuan Liu, Jingjing Wang, Jie Zhang, Yaqiong Hua, Hua Li, Huibiao Tan, Bin Kuai, Biao Wang, Sitong Sheng

Published: 2017-08-16

Everything You Need To Know

1

What exactly is Alzheimer's disease, and why is it such a concern?

Alzheimer's disease (AD) is a significant global health issue characterized by the accumulation of amyloid-beta plaques and neurofibrillary tangles in the brain. These changes disrupt normal brain function, leading to memory loss, cognitive decline, and other neurological symptoms. Understanding the factors that contribute to AD is crucial for developing effective prevention and treatment strategies.

2

What is the role of the LRP1 gene in the context of Alzheimer's disease?

The LRP1 gene, or low-density lipoprotein receptor-related protein 1, plays a critical role in clearing amyloid-beta from the brain, which is one of the hallmarks of Alzheimer's disease. It's also involved in maintaining overall brain health. Because of its role in amyloid-beta clearance, variations in LRP1 can influence a person's susceptibility to developing Alzheimer's.

3

What does it mean when researchers talk about the LRP1 C766T polymorphism?

The LRP1 C766T polymorphism is a specific variation in the LRP1 gene. This polymorphism involves a change in the DNA sequence at a particular location on the gene. Researchers investigate this polymorphism to see if it's associated with an increased or decreased risk of developing Alzheimer's disease. Different versions of the polymorphism may affect how efficiently LRP1 clears amyloid-beta, thus influencing AD risk.

4

What is a meta-analysis, and why is it useful in studying Alzheimer's disease?

A meta-analysis combines data from multiple independent studies to provide a more reliable estimate of a true association than any single study could alone. In the context of Alzheimer's disease research, a meta-analysis can help clarify the role of genetic variations like the LRP1 C766T polymorphism by increasing statistical power and reducing the impact of conflicting results from individual studies. By pooling data, researchers can identify trends and associations that might not be apparent in smaller studies.

5

What does APOE ε4 status mean, and how does it relate to the LRP1 C766T polymorphism findings?

The APOE ε4 status refers to whether a person carries the ε4 allele of the APOE gene. APOE ε4 is a well-established genetic risk factor for Alzheimer's disease. While this meta-analysis examined the APOE ε4 status, no significant interaction was observed for APOE ε4 status. This means that the LRP1 C766T polymorphism's effect on Alzheimer's risk does not appear to be significantly altered by the presence or absence of the APOE ε4 allele, suggesting that LRP1 C766T polymorphism and APOE ε4 status may influence Alzheimer's disease risk through independent pathways.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.